Boutique legal expertise for the next generation of innovators. From formation to exit, we provide the legal backbone your startup needs to scale with confidence.
Sterling Law is a boutique practice designed specifically for the unique needs of high-growth technology companies. We don't just provide legal advice; we provide strategic business intelligence.
Founded by Julian Sterling after a decade in Big Law and founding his own tech ventures, our practice combines elite legal standards with the speed and agility of a startup.
Strategic incorporation, capital structure design, and founder vesting agreements to set a solid foundation for growth.
Seed, Series A, and Series B financings. We manage the deal room, term sheet negotiations, and closing logistics.
Protecting your moat through patent strategy, trademark registration, and comprehensive trade secret protection.
SaaS agreements, data privacy policies, and complex licensing deals structured to accelerate your sales cycle.
Designing stock option plans (ESOPs), executive compensation, and remote work policies for global teams.
Strategic preparation for acquisition or IPO, including due diligence management and definitive agreement negotiation.
We navigate the complex legal landscape so you can focus on building what matters. Our process is transparent, efficient, and results-oriented.
"Julian didn't just handle our Series A; he anticipated hurdles we didn't even know existed. His experience with both law and building companies is a game-changer for any founder."
"As a health-tech startup, regulatory compliance was our biggest fear. Sterling Law navigated the HIPAA and FDA landscape with ease, allowing us to focus on our mission."
"Protecting our IP was our top priority before our seed round. The team at Sterling Law secured our core patents and structured our licensing flawlessly. Truly elite counsel."
"We always breathe a sigh of relief when we see Sterling Law on the other side of a term sheet. Julian ensures the deal is clean, fair, and built for long-term success."